Literature DB >> 14645245

Fibronectin binds insulin-like growth factor-binding protein 5 and abolishes Its ligand-dependent action on cell migration.

Qijin Xu1, Ben Yan, Shenghua Li, Cunming Duan.   

Abstract

Insulin-like growth factor-binding protein 5 (IGFBP-5) is a secreted protein that binds to insulin-like growth factors (IGFs) and modulates IGF actions on cell proliferation, differentiation, survival, and motility. IGFBP-5 also regulates these cellular events through IGF-independent mechanisms. To elucidate the molecular mechanisms governing these diverse actions of IGFBP-5, we screened a human cDNA library by a yeast two-hybrid system using IGFBP-5 as bait and identified fibronectin (FN) as a potential IGFBP-5-interacting partner. The complex formation of IGFBP-5 and FN was established by glutathione S-transferase pull-down, solution, and solid phase binding assays using glutathione S-transferase-IGFBP-5 and native IGFBP-5 in vitro and by co-immunoprecipitation in vivo. Binding assay using deletion mutants indicated that the IGFBP-5 C domain binds to the 10th and 11th type I repeats of FN. IGFBP-5 potentiated IGF-I-induced cell migration in FN-null, but not in wild-type, mouse embryonic cells. When FN was reintroduced either as an adhesive substrate or in solution to the FN-null cells, the potentiating effect of IGFBP-5 on IGF-I-induced cell migration was abolished. Binding of IGFBP-5 to FN had no effect on the ability of IGFBP-5 to bind IGF-I, but it increased the proteolytic degradation of IGFBP-5. Inhibition of IGFBP-5 proteolysis restored the potentiating effect of IGFBP-5. These results suggest that FN and IGFBP-5 bind to each other, and this binding negatively regulates the ligand-dependent action of IGFBP-5 by triggering IGFBP-5 proteolysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645245     DOI: 10.1074/jbc.M311586200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Evolving the use of peptides as components of biomaterials.

Authors:  Joel H Collier; Tatiana Segura
Journal:  Biomaterials       Date:  2011-06       Impact factor: 12.479

Review 2.  What's new in the IGF-binding proteins?

Authors:  Steven A Rosenzweig
Journal:  Growth Horm IGF Res       Date:  2004-10       Impact factor: 2.372

3.  Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.

Authors:  Tomasz Sitar; Grzegorz M Popowicz; Igor Siwanowicz; Robert Huber; Tad A Holak
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-21       Impact factor: 11.205

Review 4.  Estrogen Receptor-β and the Insulin-Like Growth Factor Axis as Potential Therapeutic Targets for Triple-Negative Breast Cancer.

Authors:  Nalo Hamilton; Diana Marquez-Garban; Vei H Mah; Yahya Elshimali; David Elashoff; Edward B Garon; Jaydutt Vadgama; Richard Pietras
Journal:  Crit Rev Oncog       Date:  2015

5.  The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface.

Authors:  Virginia D Winn; Matthew Gormley; Susan J Fisher
Journal:  Pregnancy Hypertens       Date:  2011-01-01       Impact factor: 2.899

Review 6.  Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2.

Authors:  Virginia D Winn; Matthew Gormley; Agnes C Paquet; Kasper Kjaer-Sorensen; Anita Kramer; Kristen K Rumer; Ronit Haimov-Kochman; Ru-Fang Yeh; Michael T Overgaard; Ajit Varki; Claus Oxvig; Susan J Fisher
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

7.  Cellular fibronectin response to supervised moderate aerobic training in patients with type 2 diabetes.

Authors:  Ahmad H Alghadir; Sami A Gabr; Einas Al-Eisa
Journal:  J Phys Ther Sci       Date:  2016-04-28

8.  The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms.

Authors:  Hidekata Yasuoka; Eileen Hsu; Ximena D Ruiz; Richard A Steinman; Augustine M K Choi; Carol A Feghali-Bostwick
Journal:  Am J Pathol       Date:  2009-07-23       Impact factor: 4.307

9.  The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer.

Authors:  Mustafa Akkiprik; Limei Hu; Aysegul Sahin; Xishan Hao; Wei Zhang
Journal:  BMC Cancer       Date:  2009-04-03       Impact factor: 4.430

10.  The C-terminal variable domain of LigB from Leptospira mediates binding to fibronectin.

Authors:  Yi-Pin Lin; Yung-Fu Chang
Journal:  J Vet Sci       Date:  2008-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.